Home > News > 10/The indications and safety of prolonged temporary pacing using transvenous leads and externalised pulse generator A single-centre experience
Read Time: 2 mins

10/The indications and safety of prolonged temporary pacing using transvenous leads and externalised pulse generator A single-centre experience

Published Online: October 2nd 2008 European Journal of Arrhythmia & Electrophysiology. 2019;5(Suppl. 1):abstr10
Authors: N Shah (Presenting Author) - University Hospital of Wales, Cardiff, Cardiff, UK; P Shah - University Hospital of Wales, Cardiff, Cardiff, UK; H Elsayed - University Hospital of Wales, Cardiff, Cardiff, UK; P O’Callaghan - University Hospital of Wales, Cardiff, Cardiff, UK; F Leong - University Hospital of Wales, Cardiff, Cardiff, UK; Z Yousef - University Hospital of Wales, Cardiff, Cardiff, UK
Quick Links:
Article Information

Background: Temporary cardiac pacing is an established method of pacing support in unstable bradyarrhythmias. Conventional temporary pacing is fraught with risks if used beyond few days. Extended period of pacing may be required where permanent system implant indication might either be unclear or not feasible due to an intercurrent illness. An alternative approach is using active fixation transvenous pacing leads with an externalised pulse generator. We present our experience of using this technique in a tertiary cardiac centre.

Methods: All patients who received externalised prolonged temporary pacing device (EPTP device) at University Hospital of Wales from November 2011 to April 2019 were included in the analysis. The data was retrospectively obtained from our devices database and clinical information system. The EPTP procedure was conducted in a sterile procedure room. Venous access was achieved in a standard way and new active fixation pacing leads were advanced under fluoroscopic guidance, fixed to the myocardium and sutured to the skin using the anchoring sleeve. The leads were then connected with recycled, re-sterilised pulse generator and attached to the skin using adhesive transparent dressing. Standard nursing care of the site was carried out for the duration of pacing.

Results: 68 patients with a mean age 69 ± 14 years (82% male) had an EPTP device implanted over an 8-year period. The most common indication for pacing was symptomatic high-grade AV block (68%), recurrent sinus arrest, pause-dependent ventricular tachycardia and monomorphic ventricular tachycardia. The reasons for opting an EPTP device was concomitant sepsis precluding permanent system implant (32%), need for pacing support while awaiting further investigations to confirm the diagnosis (15%) and for over drive pacing (6%). A significant number of patients were being treated on the intensive care for sepsis or organ support with post-operative status or complicated medical admission. The mean duration of pacing support was 16 ± 12 days. Subsequently, 89.5% patients had a permanent device implanted. Lead displacement was most common complication in 7 of 8 patients who experience complications. There were no deaths attributed to EPTP device placement.

Conclusions: EPTP device provides safe and reliable option for prolonged temporary pacing in patients requiring pacing support while undergoing treatment for sepsis or other intercurrent illness precluding permeant system implant. This technique is particularly useful in intensive care setting where it allows frequent patient turning without risk of lead dislodgment.

Article Information:

Further Resources

Share this Article
Related Content In Arrhythmia
43/Cardiac tamponade as a complication of transseptal puncture: associations and operatordependent variables during left atrial ablation at Barts Heart Centre
E Maclean (Presenting Author) - St Bartholomew’s Hospital, London; K Mahtani - St Bartholomew’s Hospital, London; C Butcher - St Bartholomew’s Hospital, London; N Ahluwalia - St Bartholomew’s Hospital, London; M Finlay - St Bartholomew’s Hospital, London; S Honarbakhsh - St Bartholomew’s Hospital, London; A Creta - St Bartholomew’s Hospital, London; A Chow - St Bartholomew’s Hospital, London; V Sawhney - St Bartholomew’s Hospital, London; V Ezzat - St Bartholomew’s Hospital, London; MJ Earley - St Bartholomew’s Hospital, London; M Dhinoja - St Bartholomew’s Hospital, London; S Sporton - St Bartholomew’s Hospital, London; MD Lowe - St Bartholomew’s Hospital, London; PD Lambiase - St Bartholomew’s Hospital, London; F Khan - St Bartholomew’s Hospital, London; SY Ahsan - St Bartholomew’s Hospital, London; RJ Hunter - St Bartholomew’s Hospital, London; RJ Schilling - St Bartholomew’s Hospital, London; O Sega - St Bartholomew’s Hospital, London Read Time: 2 mins

European Journal of Arrhythmia & Electrophysiology. 2021;7(Suppl. 1):abstr43

Introduction: Cardiac tamponade is a high morbidity complication of transseptal puncture (TSP). We examined the incidence and predictors of TSP-related cardiac tamponade (TRCT) for all patients undergoing left atrial ablation at our centre from 2016-2020. Methods: Patient and procedural variables were extracted retrospectively. Cases of cardiac tamponade were scrutinised to adjudicate TSP culpability. Adjusted multivariate […]

  • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72